Artificial Intelligence for Multi-omics Analysis Part B
Series: Progress in Molecular Biology and Translational Science; 222;
- Publisher's listprice EUR 122.00
-
50 599 Ft (48 190 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 5 060 Ft off)
- Discounted price 45 540 Ft (43 371 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
50 599 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 April 2026
- ISBN 9780443413490
- Binding Hardback
- No. of pages300 pages
- Size 229x152 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Artificial Intelligence for Multi-omics Analysis Part B, Volume 222 in the Progress in Molecular Biology and Translational Science series, highlights recent advances, with this new volume presenting chapters on a variety of topics, including Artificial Intelligence in multi-omics analysis of small molecule drug discovery, AI in multi-omics analysis in antimicrobial resistance, Artificial Intelligence and multi-Omics Approach in Vaccine Development, Artificial Intelligence in multi-omics Analysis of heart diseases, Artificial Intelligence in multi-omics Analysis of Kidney Diseases, Artificial Intelligence in multi-omics Analysis of Gastrointestinal Diseases, AI in multi-omics analysis in Stem cell research, and AI in multi-omics analysis in cancer, and more.
Additional sections cover AI in multi-omics analysis in obstructive lung diseases, AI in multi-omics analysis in neurodiseases, AI in multi-omics analysis in autoimmune diseases, AI in multi-omics analysis of liver diseases, AI in multi-omics analysis of COVID-19 patient data, and AI in multi-omics analysis of Type 2 diabetes.
Table of Contents:
1. Artificial Intelligence in multi-omics analysis of small molecule drug discovery
2. AI in multi-omics analysis in antimicrobial resistance
3. Artificial Intelligence and multi-Omics Approach in Vaccine Development
4. Artificial Intelligence in multi-omics Analysis of heart diseases
5. Artificial Intelligence in multi-omics Analysis of Kidney Diseases
6. Artificial Intelligence in multi-omics Analysis of Gastrointestinal Diseases
7. AI in multi-omics analysis in Stem cell research
8. AI in multi-omics analysis in cancer
9. AI in multi-omics analysis in obstructive lung diseases
10. AI in multi-omics analysis in neurodiseases
11. AI in multi-omics analysis in autoimmune diseases
12. AI in multi-omics analysis of liver diseases
13. AI in multi-omics analysis of COVID-19 patient data
14. AI in multi-omics analysis of Type 2 diabetes
